01 6Rexulti
02 5Rexulti/Rxulti
03 5Rexulti/Rxulti
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 426
2019 Revenue in Millions : 369
Growth (%) : 15
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 993
2019 Revenue in Millions : 853
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 434
2020 Revenue in Millions : 419
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 1,022
2020 Revenue in Millions : 953
Growth (%) : 16
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 560
2021 Revenue in Millions : 434
Growth (%) : 29
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 1,278
2021 Revenue in Millions : 1,022
Growth (%) : 25
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 1,417
2022 Revenue in Millions : 1,278
Growth (%) : 26
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 652
2022 Revenue in Millions : 560
Growth (%) : 16
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 18
Growth (%) : New Launch
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 212
2016 Revenue in Millions : 140
Growth (%) : 51
LOOKING FOR A SUPPLIER?